Once-Daily Weight Loss Pill
Foundayo™ is the first oral, non-peptide GLP-1 receptor agonist approved for chronic weight management. Developed by Eli Lilly, it offers a highly effective, once-daily pill alternative for patients looking to avoid weekly injections.
Key Features & Benefits
- No Injections:A simple, once-daily tablet.
- Flexible Routine:Can be taken at any time of day, with or without food, and with no strict water restrictions.
- FDA-Approved:Approved in April 2026 for adults with obesity ($BMI \ge 30$), or adults with overweight ($BMI \ge 27$) who have at least one weight-related medical condition.
- Targeted Appetite Control:Functions as a GLP-1 receptor partial agonist to reduce appetite, slow digestion, and support healthy blood sugar regulation.
Expected Weight Loss Results
In the landmark phase 3 ATTAIN-1 clinical trial spanning 72 weeks:
- Average Weight Loss:Participants taking the highest daily dose achieved an average weight loss of up to 11–12% of their total body weight.
- Placebo Comparison:The control group taking a placebo lost an average of roughly 2% during the same period.
- Cardiometabolic Perks:Clinical data also demonstrated measurable improvements in waist circumference, systolic blood pressure, and cholesterol markers.
Common Side Effects & Safety
Like all GLP-1 medications, Foundayo primarily affects the digestive tract as your body adjusts to the medication. Side effects are most common during the initial weeks or when increasing your dose.
Most Common Side Effects:
- Nausea and vomiting
- Constipation or diarrhea
- Indigestion, heartburn, and gas
- Abdominal pain or bloating
- Fatigue and mild headaches
Clinical Note: Foundayo carries standard GLP-1 warnings and is not suitable for everyone, including individuals who are pregnant, planning to become pregnant, or currently taking another GLP-1 medication. A comprehensive medical history review is required.
How It Compares to Other Oral Options
Unlike older oral semaglutide options, Foundayo is a small-molecule (non-peptide) medication. Because it is not a peptide, your digestive enzymes do not break it down.
This molecular difference eliminates the need for strict morning fasting routines. You do not have to wait 30 minutes before eating, and you do not need to limit your water intake when taking your daily dose.
Get Evaluated Globally from Illinois
Our board-certified obesity medicine physicians provide private, secure telehealth consultations across the entire state of Illinois. If Foundayo is medically appropriate for your weight loss goals, your prescription will be sent directly to your local Chicagoland pharmacy or preferred mail-order service.